Laborie is set to exit the medical device manufacturer after another of its investors, Olympus, announced its intention to pay $260m for its remaining shares.
Camera and optics technology producer Olympus has agreed to acquire one of its portfolio companies, Israel-based medical device maker Medi-Tate for $260m. Olympus invested an undisclosed amount in Medi-Tate in 2018 as part of a distribution agreement, and held an 18.5% stake prior to the transaction, which involves it exercising a call option to buy…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
